NCT04241094

Brief Summary

PTSD occurs in as many as 17% of US military Veterans and is associated with a host of negative, long-term consequences to the individual, their families, and society at large. EBPs, such as Prolonged Exposure, result in clinically significant symptom relief for many. Yet, these therapies have proven less effective for military personnel and Veterans and treatment dropout rates are high. The investigators' team surveyed Veterans initiating EBPs for PTSD and a family member across four VA medical centers (N = 598; Project HomeFront). The investigators found that Veterans were more than twice as likely to complete EBPs when loved ones encouraged them to confront distress and that Veterans experienced greater treatment gains when they shared more with their loved ones about their treatment. A couples-based, exposure therapy for PTSD that integrates intimate partners into every session of PE could provide the opportunity to mobilize the whole household in the service of EBP engagement, while extending the goals of therapy beyond symptom reduction to family functioning. The investigators anticipate this intervention will teach couples to embrace a lifestyle that supports confronting trauma-related distress, so the Veteran and his/her family can achieve optimal functional outcomes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
28

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Nov 2020

Geographic Reach
1 country

3 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 22, 2020

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 27, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

November 2, 2020

Completed
1.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
2 years until next milestone

Results Posted

Study results publicly available

July 1, 2024

Completed
Last Updated

July 1, 2024

Status Verified

March 1, 2024

Enrollment Period

1.7 years

First QC Date

January 22, 2020

Results QC Date

June 8, 2023

Last Update Submit

March 19, 2024

Conditions

Keywords

Posttraumatic Stress DisorderCouples therapyPsychotherapyVeterans

Outcome Measures

Primary Outcomes (1)

  • Clinician Administered PTSD Scale for DSM-5 to Assess Changes in PTSD Symptoms.

    Structured clinical interview assessing symptoms of PTSD. CAPS-5 is a 30-item questionnaire, corresponding to the DSM-5 diagnosis for PTSD. CAPS-5 total symptom severity score is calculated by summing severity scores for the 20 DSM-5 PTSD symptoms. Similarly, CAPS-5 symptom cluster severity scores are calculated by summing the individual item severity scores for symptoms corresponding to a given DSM-5 cluster: Criterion B (items 1-5); Criterion C (items 6-7); Criterion D (items 8-14); and, Criterion E (items 15-20). A symptom cluster score may also be calculated for dissociation by summing items 19 and 20. Severity scores range from 0 to 80 and higher scores correspond with more severe symptoms of PTSD.

    Up to 26 weeks post baseline

Study Arms (1)

Loved one assisted treatment

EXPERIMENTAL

The investigators propose to bring a loved one into PE, one of the most researched and efficacious treatments for PTSD, to increase support for PE adherence. The intervention is a 13-session cognitive-behavioral, intimate partner-assisted treatment for PTSD that draws from PE, ICBT, and PE2.

Behavioral: Loved one assisted treatment

Interventions

The investigators propose to bring a loved one into PE, one of the most researched and efficacious treatments for PTSD, to increase support for PE adherence. The intervention is a 13-session cognitive-behavioral, intimate partner-assisted treatment for PTSD that draws from PE, ICBT, and PE2.

Loved one assisted treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Enrolled in VHA care
  • Clinically significant PTSD symptoms
  • Have a LO (loved one/intimate partner) with whom they have been in a romantic relationship with for 6 months
  • Will allow a LO to participate
  • Willing to be seen via telehealth when in-person treatment options aren't available.

You may not qualify if:

  • Actively suicidal/homicidal with intent and/or plan
  • Episode of mania/ psychosis in past 3 months
  • Severe substance use problem in past 3 months
  • Moderate relationship violence
  • Veteran has underlying medical condition or a planned medical procedure likely to impair ability to engage in treatment.
  • LO screens positive for PTSD
  • Veteran and/or LO fails to complete baseline survey

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033, United States

Location

VA Ann Arbor Healthcare System, Ann Arbor, MI

Ann Arbor, Michigan, 48105, United States

Location

Minneapolis VA Health Care System, Minneapolis, MN

Minneapolis, Minnesota, 55417, United States

Location

MeSH Terms

Conditions

Stress Disorders, Post-Traumatic

Condition Hierarchy (Ancestors)

Stress Disorders, TraumaticTrauma and Stressor Related DisordersMental Disorders

Limitations and Caveats

Small number of subjects analyzed

Results Point of Contact

Title
Laura Meis, PhD
Organization
Center for Care Delivery & Outcomes Research

Study Officials

  • Laura A. Meis, PhD

    Minneapolis VA Health Care System, Minneapolis, MN

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
Yes
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Open trial
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 22, 2020

First Posted

January 27, 2020

Study Start

November 2, 2020

Primary Completion

June 30, 2022

Study Completion

June 30, 2022

Last Updated

July 1, 2024

Results First Posted

July 1, 2024

Record last verified: 2024-03

Data Sharing

IPD Sharing
Will not share

Locations